Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC 18-19 th September, 2012.

Slides:



Advertisements
Similar presentations
Global Measles and Rubella Strategic Plan
Advertisements

Measles elimination in the African Region- Regional updates
1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
Measles Outbreaks in Southern Africa in 2010 Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Measles and Rubella Elimination in the WHO European Region: Update on Progress & Challenges Global Measles and Rubella Management Meeting March 2011.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Strengthening Routine Infant Immunization in EMR Partners for Measles Advocacy February, 2007 Eastern Mediterranean Regional Office Vaccines Preventable.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Ann Levin, Colleen Burgess, Lou Garrison, Chris Bauch, and Joseph Babigumira Measles Initiative Meeting Washington, D.C. September 13,
World Health Organization
Routine Immunization: The Missed Child Perspective Maya van den Ent, PharmD MPH Edward Hoekstra, MD, MSc David Brown, DSc, MScPH, MSc Halima Dao, MD, MSc.
Global Immunization Performance Update through 2011.
National Immunization Program Report NVAC Washington, DC  February 3-4, 2004 Stephen L. Cochi, M.D., M.P.H. Acting Director, National Immunization Program.
1 AFRO Measles TAG – Nairobi 2-3 June 2015 MCV2 Introduction and the Second Year of Life Contact Lessons and way forward Raoul KAMADJEU UNICEF ESARO Meeting.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Update on the Implementation of Measles 2 nd Dose in India Ms. Anuradha Gupta Joint Secretary, Ministry of Health Govt. of India Global Measles and Rubella.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
Palestine Bahrain Global Measles and Rubella Management Meeting Boubker Naouri March, 2011 Geneva, WHO HQ.
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
Update on Measles Mortality Reduction Activities and Linkages with RI.
Measles Initiative Management and Financing September 13, 2011.
Barriers to achieving the health MDGs and how these can be overcome Action for Global Health UK Policy Conference London, 28 June 2010 Isabelle de Zoysa.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Measles Partnership Meeting Update on Vaccine Supply Washington, 27-28th February 2007 UNICEF Supply Division.
1 Progress Towards Global and Regional Immunization Goals Workshop on Prevention and Control of Vaccine Preventable Disease in Displaced Person Temporary.
Funding Update: 2013 – 2015 September 10,
Funding Update GMMM March 21, 2012 Andrea Gay, UNF Athalia Christie, ARC Rebecca Martin, CDC 1.
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
AFR MR TAG Global Measles and Rubella Update 5 th African Regional Measles/Rubella TAG Meeting 2 nd -3 rd June 2015.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Gavi’s Measles and Rubella Programme:Update Stefano Malvolti September 2015, Washington DC Page: 1 Reach every child.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
National Immunization Conference Hilleman Lecture: Achieving Global Immunization for All: Can We Do the Right Thing? Stephen Cochi, MD, MPH Senior Advisor.
GAVI’S NEW MEASLES AND RUBELLA STRATEGY Dr. Khin Devi Aung Gavi Secretariat 21 June 2016, Geneva 1 #vaccineswork.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
Measles mortality reduction in SEAR
World Health Organization
2017 Measles & Rubella Initiative Partners’ Meeting
Session 4 Cross Cutting MR and RI Priorities Introduction
Strengthening the 2YL Platform & Men A Introduction Plan in Ghana
Global Overview of Measles
Measles Containing Vaccines
Measles & Rubella Initiative Partners meeting September 7-8, 2017
Progress and Challenges with achieving Universal Immunization Coverage
World Health Organization
Session 1: New Opportunities and New Direction
مراقبت بيماريهاي بثوري تب دار باهدف حذف سرخك و سرخجه
Stakeholder Consultation
African Region- priorities to reach the 2020 measles elimination goal.
Funding Update: Current Situation and Future Prospects
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Measles and Rubella Elimination Goals by WHO Region, 2012
World Health Organization
Presentation transcript:

Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012

Major causes of annual under 5yrs child mortality: : 9.6 million 2010 : 7.6 million Source: Li, Liu, at all The Lancet 379, June 9, 2012): 1990: 12.1 million 2008: 8.8 million Source: Van den Ent et al, J Infect Dis Suppl July 2011

Estimated measles deaths down by three - quarters, Target 74%

4 |4 | Trends in 1 st and 2 nd dose Measles delivery various strategies Number of doses of measles vaccine administered, by delivery strategy, Measles Initiative 1 st routine dose: WHO/UNICEF coverage estimates, The World Population Prospects New York, nd routine dose: WHO/UNICEF Joint reporting form, (not all countries report 2 nd dose). SIA dose;: WHO SIA database, July 2011 (Provisional data) 1 billion vaccinated as of July 2011

Measles and other interventions supplementary activities, 2011 Vitamin A – 12 De-worming – 10 Bed nets – 2 OPV – 16 Other interventions -5 WHO;August 2012 *OPV+VitA+Deworming+Mealses

6 |6 | 84% 2015 Target Annual Number of Reported Measles Cases and 1 st Dose Measles Vaccination Coverage, Worldwide,

7 |7 | Reduction in Estimated Measles Deaths by WHO Region 2000 to %76%79%85% 2010 reduction goal (90%) 78% Source: WHO/IVB, November %100% 26%

8 |8 | Pareto-Juran principle 20% of the work (the first 10% and the last 10%) consume 80% of your time and resources

9 |9 | India Phase 2 (157 districts) Phase 1 (45 districts covered) Remaining (159 districts) Source: Based on target population available with GoI Target pop (millions) Vaccinated (millions) Coverage Phase % Phase %* Phase-372.7Planned-- Total *-- * Phase-2 campaigns ongoing; data as on 23 Jan states with MCV1 coverage ≥ 80% introduced a routine second dose by August states with MCV1 < 80% are implementing measles SIAs

10 | Measles and Rubella Elimination Goals by WHO Region, February SEAR: 95% Mortality Reduction by 2015 Americas, Europe, E. Mediterranean, W. Pacific, Africa have measles elimination goals Americas and Europe have rubella elimination goals

Political advocacy, mobilizing decision makers Branding, advertising & ‘edu-tainment’ with national, provincial and community mass media Community engagement Meetings, forums, film showings and events Targeted selling Volunteer Social Mobilization Networks Point of service promotion Inter-personal communication Researched & Evidenced multi- pronged communication: Experience from GPEI COMBI Star adapted for polio eradication Challenges 1: Communication

12 | Challenges 2: Weak Immunization Systems 1 st dose: –67 Countries have MCV1 coverage < 90% 2 nd dose ( routine ): –54 countries do not have routine 2 nd dose Campaigns: –Variable quality Measles 1 st dose coverage among infants, % (24 countries or 12 %) 50-79% (41 countries or 21%) >=90% (126 countries or 66%) <50% (2 countries or 1%)

13 | Challenges 3: Some set backs in Africa 4-fold increase since 2008 Large outbreaks in Burkina Faso (2009), S. Africa (2010), and DRC (2011) Outbreaks in drought affected Horn of Africa –High case-fatality Weekly Epidemiological Record (2011) 86:

14 | Historical procurement of Measles and MR vaccine through UNICEF in and forecasts for (in doses)

15 |SummarySummary Achievements –1 st dose coverage up to 85% –1 billion doses delivered in campaigns –2 / 3 reduction in cases –3 / 4 reduction in deaths Challenges –Catch - up in India; Outbreaks in Africa; Weak systems New Strategic Plan, 2012 – 2020 –Addressing rubella together with Measles –Taking the Initiative towards achieving regional goals More Harambee